Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | Any - 17 |
| Updated: | 4/6/2019 |
| Start Date: | February 8, 2019 |
| End Date: | December 1, 2020 |
| Contact: | Viviane Nasr, MD |
| Email: | viviane.nasr@childrens.harvard.edu |
| Phone: | 617-355-6225 |
This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and
midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO)
aiming to understand the pharmacokinetics of these drugs in this setting.
midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO)
aiming to understand the pharmacokinetics of these drugs in this setting.
Inclusion Criteria:
- supported on ECMO
- receiving one or a combination of the following drugs dexmedetomidine, fentanyl,
midazolam or morphine as part of sedation management
Exclusion Criteria:
We found this trial at
1
site
300 Longwood Ave
Boston, Massachusetts 02115
Boston, Massachusetts 02115
(617) 355-6000
Principal Investigator: Viviane Nasr, MD
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials
